INJ #131 by market cap DCA Plan

Research playbook

Injective DCA plan

Injective is a INJ market beta asset trading near $3.03, with $303.19M in market cap and -1.11% over seven days. This page focuses on cadence, expectation-setting, drawdown tolerance, and whether the asset is suitable for repeat buying.

Decision Checklist

Would this asset fit a recurring-buy plan?

Current role: INJ market beta asset.

Market cap: $303.19M.

24h volume: $38.31M.

Seven-day direction: -1.11%, currently weaker versus the tracked board.

Would this asset fit a recurring-buy plan?

Market stats

Injective snapshot

$3.03 -1.11% 7d

Injective carries $303.19M in market cap and $38.31M in 24 hour volume. Use those numbers as context, then follow the links below to pressure-test the decision.